Artelo Biosciences Files 2024 10-K
Ticker: ARTL · Form: 10-K · Filed: Mar 3, 2025 · CIK: 1621221
Sentiment: neutral
Topics: 10-K, annual-report, pharmaceuticals
TL;DR
ARTL 10-K filed: FY24 financials out, Nevada corp, CA address.
AI Summary
Artelo Biosciences, Inc. filed its 10-K for the fiscal year ending December 31, 2024. The company, formerly known as Reactive Medical Inc. and Knight Knox Development Corp., is incorporated in Nevada and operates in the Pharmaceutical Preparations sector. Its principal business address is in Solana Beach, California.
Why It Matters
This filing provides a comprehensive overview of Artelo Biosciences' financial performance and operational status for the past fiscal year, crucial for investors and stakeholders to assess the company's health and future prospects.
Risk Assessment
Risk Level: medium — As a pharmaceutical company, Artelo Biosciences faces inherent risks related to drug development, regulatory approvals, and market competition, which are typical for the industry.
Key Numbers
- 2024-12-31 — Fiscal Year End (Reporting period for the 10-K)
- 2025-03-03 — Filing Date (Date the 10-K was submitted to the SEC)
Key Players & Entities
- ARTELO BIOSCIENCES, INC. (company) — Filer
- 2024-12-31 (date) — Fiscal Year End
- 2025-03-03 (date) — Filing Date
- Solana Beach, CA (location) — Business Address
- REACTIVE MEDICAL INC. (company) — Former Company Name
- KNIGHT KNOX DEVELOPMENT CORP. (company) — Former Company Name
FAQ
What is Artelo Biosciences, Inc.'s primary business sector?
Artelo Biosciences, Inc. operates in the Pharmaceutical Preparations sector, with the Standard Industrial Classification code 2834.
When did Artelo Biosciences, Inc. change its name from Reactive Medical Inc.?
The company changed its name from Reactive Medical Inc. on February 7, 2017.
What is the filing date for this 10-K report?
This 10-K report was filed on March 3, 2025.
Where is Artelo Biosciences, Inc. located?
Artelo Biosciences, Inc. is located at 505 Lomas Santa Fe, Suite 160, Solana Beach, CA 92075.
What is the fiscal year end for this filing?
The fiscal year end for this filing is December 31, 2024.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on March 3, 2025 regarding ARTELO BIOSCIENCES, INC. (ARTL).